• Investing Ideas
  • /
  • Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
104 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

512

Grand Pharmaceutical Group
HK$4.114.1%-8.3%HK$14.4bn/aPE7.7xE20.0%6.3%

2315

Biocytogen Pharmaceuticals (Beijing)
HK$8.65-0.6%-65.3%HK$3.5bHK$18.50PS4.5xE123.6%n/a

6600

SciClone Pharmaceuticals (Holdings)
HK$16.040%57.6%HK$9.8bHK$15.80PE8xE1.2%2.3%

1889

Sanai Health Industry Group
HK$0.04-7.0%-46.7%HK$128.4mn/aPE6.4xn/a0%

1877

Shanghai Junshi Biosciences
HK$9.87-2.1%-64.3%HK$24.7bHK$31.58PS6xE51.6%n/a

3759

Pharmaron Beijing
CN¥9.58-1.0%-57.2%CN¥32.9bCN¥13.36PE23.5xE13.2%1.0%

2877

China Shineway Pharmaceutical Group
HK$9.73-1.7%n/aHK$7.4bHK$10.59PE7xE13.6%4.7%

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.74-0.6%65.7%HK$974.8mn/aPE6.1xn/a31.1%

2877

China Shineway Pharmaceutical Group
HK$9.73-1.7%n/aHK$7.4bHK$10.59PE7xE13.6%4.7%

1558

YiChang HEC ChangJiang Pharmaceutical
HK$10.88-0.9%43.5%HK$9.6bHK$11.41PE4.4xS3.1%0%

9939

Kintor Pharmaceutical
HK$1.15-17.3%n/aHK$514.6mHK$16.05PB0.3xE4.0%n/a

1643

Modern Chinese Medicine Group
HK$0.372.8%-30.2%HK$222.0mn/aPE4.2xn/a0%

2696

Shanghai Henlius Biotech
HK$13.62-2.0%15.6%HK$7.4bHK$17.78PE12.5xE15.9%n/a

9939

Kintor Pharmaceutical
HK$0.86-6.5%-86.4%HK$384.8mHK$14.51PB0.8xE27.0%n/a

2269

WuXi Biologics (Cayman)
HK$14.302.0%-69.8%HK$59.7bHK$36.28PE16.2xE15.4%n/a

6826

Shanghai Haohai Biological Technology
HK$40.00-0.4%-5.0%HK$15.9bHK$70.01PE14.9xE22.4%2.7%

6600

SciClone Pharmaceuticals (Holdings)
HK$16.040%57.6%HK$9.8bHK$15.80PE8xE1.2%2.3%

2256

Abbisko Cayman
HK$2.882.1%-0.7%HK$1.7bHK$8.20PS82.6xE-2.3%n/a

3347

Hangzhou Tigermed Consulting
CN¥29.601.0%-59.5%CN¥42.8bCN¥36.66PE22.7xE17.2%1.1%

1011

China NT Pharma Group
HK$0.022-26.7%-68.6%HK$58.1mn/aPS1.1xn/a0%

512

Grand Pharmaceutical Group
HK$4.114.1%-8.3%HK$14.4bn/aPE7.7xE20.0%6.3%

9926

Akeso
HK$46.650.1%18.0%HK$40.4bHK$59.81PE18.4xE12.4%n/a

1093

CSPC Pharmaceutical Group
HK$6.15-3.0%-19.9%HK$72.9bHK$9.33PE11.5xE4.3%4.5%

9926

Akeso
HK$46.650.1%18.0%HK$40.4bHK$59.81PE18.4xE12.4%n/a
Page 2 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.